Abbott's new consumer biowearables technology will track key biomarkers in the body such as glucose, ketones, lactate, and alcohol, to help consumers better understand their health and wellness.
FDA backlog has delayed potential approval timing for Senseonics' 180-day Eversense continuous glucose monitor. A decision was previously expected by the end of 2021.
An industry thought leader says medical device manufacturers often fail to fully realize commercial opportunities in emerging markets.
Neovasc enrolled the first patient in a pivotal trial of a device that reduces angina symptoms in patients with refractory angina.
Boston Scientific and GE Healthcare are bringing their interventional cardiology portfolios to cardiac care centers.
42 Technology partnered with FIND and Rutgers University to develop a solution for diagnosing tuberculosis in children.
Proximie’s platform will enable surgeons to 'virtually transport' into any operating room in the world to visually interact with and guide surgeons.
